SCHEMBL697594

SCHEMBL697594

C=C(c1cccc(CC)c1C)c1nccn1Cc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
AGTR1 P30556 1/20 0.39
AGTR2 P50052 1/20 0.39
BRD4 O60885 2/20 0.39
ALDH1A1 P00352 1/20 0.39
NOTUM Q6P988 1/20 0.39
HSD17B10 Q99714 1/20 0.38
FDPS P14324 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL699209 0.87 RAB9A (0.46) RAB9ANPC1SMN1; SMN2BRD4ALDH1A1
SCHEMBL28790638 0.85 RAB9A (0.41) RAB9ANPC1SMN1; SMN2AGTR1AGTR2
SCHEMBL696960 0.85 RAB9A (0.44) RAB9ANPC1SMN1; SMN2BRD4ALDH1A1
SCHEMBL697825 0.83 RAB9A (0.42) RAB9ANPC1SMN1; SMN2HSD17B10OPRD1
SCHEMBL696695 0.82 RAB9A (0.42) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL696521 0.81 RAB9A (0.45) RAB9ANPC1SMN1; SMN2BRD4ALDH1A1
SCHEMBL698005 0.81 RAB9A (0.41) RAB9ANPC1SMN1; SMN2BRD4ALDH1A1
SCHEMBL705643 0.80 RAB9A (0.44) RAB9ANPC1SMN1; SMN2BRD4ALDH1A1
SCHEMBL27826896 0.80 RAB9A (0.44) RAB9ANPC1SMN1; SMN2ALDH1A1HSD17B10
SCHEMBL697953 0.80 RAB9A (0.42) RAB9ANPC1SMN1; SMN2BRD4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423199-A1 Substituted imidazoles and their use as pesticides Pfizer Limited (GB) 2012-02-29 EP disclosed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 RAB9A 777/4885NPC1 745/4885SMN1; SMN2 1394/4885
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 RAB9A 777/4885NPC1 745/4885SMN1; SMN2 1394/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 RAB9A 777/4885NPC1 745/4885SMN1; SMN2 1394/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 RAB9A 777/4885NPC1 745/4885SMN1; SMN2 1394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.